Articles from VisualDx

VisualDx and Perplexity today announced a new partnership that brings clinician-validated medical images directly into AI-powered health answers. VisualDx, a leading clinical decision support system used by healthcare professionals worldwide, is now part of Perplexity’s Premium Health Sources along with leading medical organizations including The New England Journal of Medicine (NEJM), The BMJ, EBSCO Information Services, American Heart Association, and more.

VisualDx, an award-winning web-based clinical decision support system, has received a grant from the Bill & Melinda Gates Foundation to develop diagnostic and surveillance tools to help medical providers improve treatment decisions and outcomes in underserved areas. VisualDx will expand equitable access to its clinical decision support, artificial intelligence (AI) and machine learning (ML) tools to provide guidance, specialist knowledge, and education for providers in low-resource settings.

The Vermont Department of Health has launched a first-of-a-kind program to support healthcare professionals with timely information on disease diagnosis, testing, treatment and patient education resources — improving public health response statewide.

Ahead of the American College of Emergency Physicians (ACEP) Scientific Assembly (October 1-4), VisualDx today announced a collaboration with ACEP to create the Monkeypox Emergency Medicine Project, a physician-sourced collection of monkeypox images. By offering access to images of varying disease presentations on real patients, VisualDx and ACEP are helping to further educate and prepare emergency physicians to test, diagnose, and treat the emergent disease.

Ahead of this week’s American Academy of Dermatology’s (AAD) Annual Meeting (March 25-29), VisualDx today announced it is celebrating the one-year anniversary of Project IMPACT (Improving Medicine’s Power to Address Care and Treatment), a global effort to reduce disparities in medicine, highlight ways to bridge gaps of knowledge, and improve healthcare outcomes for patients of color. Since launching in March 2021, Project IMPACT has reached 1.5 million healthcare professionals and students globally and has garnered early notoriety and momentum with support from inaugural members like the Skin of Color Society (SOCS) and New England Journal of Medicine (NEJM) Group. Project IMPACT now boasts eight collaborating organizations, including the AAD, American Medical Women’s Association, and the Student National Medical Association.

VisualDx, a global leader in web-based clinical decision support (CDS), today announced that it has entered into an agreement with Janssen Biotech, Inc., one of the pharmaceutical companies of Johnson & Johnson. Through this collaboration, the Research & Development data science team at Janssen will leverage the VisualDx application programming interface (API) as a beta partner and the new interface will enable provider organizations and other healthcare technology companies to bring VisualDx’s industry-defining CDS into third-party applications to enhance diagnostic accuracy and improve health outcomes, particularly for traditionally marginalized patient populations. This agreement was facilitated by Johnson & Johnson Innovation.

VisualDx, an award-winning web-based clinical decision support system, has partnered with Osmosis.org, a leading health education platform, to increase medical and health professional, as well as student and faculty, access to both organizations’ leading content libraries. Through this collaboration, VisualDx and Osmosis will integrate their platforms to bolster the educational resources they provide to medical schools nationwide.